Navigation auf uzh.ch

Suche

URPP ITINERARE

4th Rare Disease Summer School

Veranstaltung in englischer Sprache

Wednesday, July 13th to Friday, July 15th 2016 Tagungszentrum Schloss Au, Wädenswil (on lake Zurich)

SS2016

The 4th Rare Diseases Summer School was attended by 29 young clinicians and researchers of which 34.5% came from Zurich, 27.6% from other parts of Switzerland and 37.9% from six other countries, resulting in the most international RDSS so far. This together with the fact that this year was the first time with a waiting list of participants shows that the Rare Diseases Summer School is increasing its popularity in Switzerland and abroad, attracting more students every year. The participants rated the Rare Diseases Summer School 2016 very highly in their evaluations. In particular 75% of the lectures were rated as excellent and the other lectures as good.

The curriculum and format of the Summer School foster networking, which our surveys of past participants have shown leads to concrete collaborations and is highly beneficial to the participants. This is in line with the UZH Internationalization Strategy 2014–2020, which proposes summer schools as a measure "to give junior researchers the opportunity to establish and maintain professional networks.”

Social activities

Dinner Au 2016

 

Networking Dinner at Landgasthof Au Restaurant with a beautiful view over the lake of Zurich and the Alps
 
Wein Museum Au

 

Apéro and guided visit at the Wine Museum in Au for an oenological journey through time

 

Weiterführende Informationen

Congratulations to the winners of the poster prizes

Isabelle Céline Windheuser,
University of Bonn

 

Maria Madalena Barroso,
Ludwig-Maximilians-Universität Munich

Participant Website

What participants of the 4th Rare Diseases Summer School said...

"For me it was the first time to see and hear about the struggle of patients for the approval of a drug. It was highly interesting and emotional. Good to hear the patient's researcher view!"


"Small group, great venue, super organization, good mix of topics (clinical, research, patient views), and nice workshops!"

Speakers (in alphabetical order)

Dr. Jasmin Barman-Aksözen, Scientific advisor, Swiss society for porphyria: Clinical trial design and approval process
Dr. Cécile de Coster, Alexion Pharma International: Regulatory Frameworks
Christina Fasser, Vice-President ProRaris, President Retina International: Patient-initiated research
Prof. Nine Knoers, University Medical Centre Utrecht, Utrecht, The Netherlands: Exome sequencing
Prof. Stephan Neuhauss, University of Zurich: Model organisms
Samantha Parker, LYSOGENE, France: Rare disease registries
Prof. Janine Reichenbach, Children's Hospital Zurich: Clinical gene therapy for X-linked Chronic Granulomatous Disease  
Prof. Guenter Schwarz, Cologne University: Drug development
Dr. Jürg Streuli, University of Zurich: Ethical considerations
Prof. Marshall Summar, Children‘s National Medical Center, George Washington University, Washington DC, USA: Clinical endpoints
Dr. Cynthia J. Tifft, Director, Pediatric Undiagnosed Diseases Program
National Human Genome Research Institute/NIH: Keynote Lecture
Prof. Effy Vayena, University of Zurich: Ethical considerations
Prof. Carsten Wagner, University of Zurich: Model organisms
Dr. Martine Zimmermann, Alexion Pharma International: Regulatory Frameworks